Literature DB >> 224974

Behavioral and biochemical analysis of GABA-mediated inhibition in the early chick embryo.

J L Reitzel, J L Maderdrut, R W Oppenheim.   

Abstract

Exogenous gamma-aminobutyric acid (GABA) decreased spontaneous motility in 4-, 6-, 7-, 9-, and 13-day chick embryos; the younger embryos were more sensitive. Neither the positional isomers of GABA, alpha-aminobutyric acid (AABA) and beta-aminobutyric acid, nor the principle GABA catabolite, succinic acid, decreased motility in 4-day embryos. Several semi-rigid GABA analogues decreased motility in 4-day embryos with a potency that paralleled their effectiveness in displacing [3H]GABA in ligand-binding studies. The effects of AABA and GABA on hind-limb motility were quantitatively similar in thoracic spinal and sham-operated 7-day embryos. Bicuculline and picrotoxin elicited absolute motility increases at 6, 7 and 9 days of incubation. Picrotoxin and two bicyclophosphate GABA antagnoists elicited relative motility increases while bicuculline elicited an absolute motility increase at 4 days. The two bicyclophosphates increased motility with a potency that paralleled their electrophysiological effectiveness. L-Glutamic acid decarboxylase (GAD) activity was detected in the embryonic lumbar spinal cord at all ages examined (3--7 days) using a new radiometric cation-exchange method. Gamma-Aminobutyric acid transaminase (GABA-T) activity was detected in the lumbar spinal cord at the earliest age examined (day 5). Both GAD and GABA-T activity were detected at earlier ages than previously reported. GABA receptors, and the enzymes necessary for the synthesis and degradation of GABA, all appear to be present at (or before) the onset of spontaneous motility. GABA-mediated transmission appears to be present at 6 days and perhaps as early as 4 days.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 224974     DOI: 10.1016/0006-8993(79)90581-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  GABA and behavioral inhibition in the neonatal rat pup.

Authors:  L P Spear; J Penson; D G Linville
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  A radiometric microassay for gamma-aminobutyric acid (GABA) transaminase.

Authors:  J L Maderdrut
Journal:  Neurochem Res       Date:  1986-03       Impact factor: 3.996

3.  Ontogeny of GABA-ergic and dopaminergic mediation of gnawing behavior in the mouse.

Authors:  E Tirelli
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Maternally derived hormones, neurosteroids and the development of behaviour.

Authors:  James C Mouton; Renée A Duckworth
Journal:  Proc Biol Sci       Date:  2021-01-27       Impact factor: 5.349

5.  Neuromuscular activity blockade induced by muscimol and d-tubocurarine differentially affects the survival of embryonic chick motoneurons.

Authors:  M F Usiak; L T Landmesser
Journal:  J Neurosci       Date:  1999-09-15       Impact factor: 6.167

Review 6.  Physiological and behavioral studies with muscimol.

Authors:  F V DeFeudis
Journal:  Neurochem Res       Date:  1980-10       Impact factor: 3.996

7.  A developmental shift from GABAergic to glycinergic transmission in the central auditory system.

Authors:  V C Kotak; S Korada; I R Schwartz; D H Sanes
Journal:  J Neurosci       Date:  1998-06-15       Impact factor: 6.167

8.  The multifunctional protein PACS-1 is required for HDAC2- and HDAC3-dependent chromatin maturation and genomic stability.

Authors:  Chinnadurai Mani; Kaushlendra Tripathi; Shan Luan; David W Clark; Joel F Andrews; Alessandro Vindigni; Gary Thomas; Komaraiah Palle
Journal:  Oncogene       Date:  2020-01-27       Impact factor: 9.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.